Detalhe da pesquisa
1.
Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.
Genes Chromosomes Cancer
; 59(2): 96-105, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469468
2.
Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes.
J Pharmacol Exp Ther
; 369(3): 428-442, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894455
3.
Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
Ann Rheum Dis
; 78(5): 641-647, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826774
4.
ß-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
J Allergy Clin Immunol
; 139(3): 923-932.e8, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502297
5.
The effect of LCZ696 (sacubitril/valsartan) on amyloid-ß concentrations in cerebrospinal fluid in healthy subjects.
Br J Clin Pharmacol
; 81(5): 878-90, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663387
6.
Development, validation and application of a liquid chromatography-tandem mass spectrometry method for the activity and inhibition of DPP-4.
Bioanalysis
; 14(6): 369-378, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249375
7.
Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study.
Diabetes Metab Syndr
; 16(3): 102438, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272176
8.
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Neurology
; 96(18): e2296-e2312, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827960
9.
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
Lancet Neurol
; 20(9): 739-752, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418401
10.
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
Lancet Rheumatol
; 2(3): e142-e152, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263652
11.
Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.
J Clin Invest
; 127(6): 2148-2158, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436937
12.
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.
Arthritis Res Ther
; 19(1): 13, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115015
13.
¹8F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study.
J Bone Miner Res
; 28(6): 1337-47, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322666
14.
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
J Pharm Biomed Anal
; 55(5): 869-77, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21530130
15.
Reduction of matrix interferences by the combination of chaotropic salt and DMSO in a broadly applicable target-based ELISA for pharmacokinetic studies of therapeutic monoclonal antibodies.
J Pharm Biomed Anal
; 50(5): 924-31, 2009 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608373